Inventor
HARLEY CALVIN B
US34 patents
⚠️ This page may combine multiple inventors who share the name “HARLEY CALVIN B”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
GERON CORP
16 patentsUS6444650B1Sep 3, 2002
Antisense compositions for detecting and inhibiting telomerase reverse transcriptase
GERON CORP109 citations99
US6261836B1Jul 17, 2001
Telomerase
GERON CORP153 citations99
US6627619B2Sep 30, 2003
Antisense compositions for detecting and inhibiting telomerase reverse transcriptase
GERON CORP42 citations96
US6617110B1Sep 9, 2003
Cells immortalized with telomerase reverse transcriptase for use in drug screening
GERON CORP69 citations96
US7585622B1Sep 8, 2009
Increasing the proliferative capacity of cells using telomerase reverse transcriptase
GERON CORP14 citations93
US7297488B2Nov 20, 2007
Identifying and testing antisense oligonucleotides that inhibit telomerase reverse transcriptase
GERON CORP20 citations93
US6921664B2Jul 26, 2005
Telomerase
GERON CORP21 citations93
US5629154AMay 13, 1997
Telomerase activity assays
GERON CORP62 citations93
US7262174B2Aug 28, 2007
Treatment for wounds
GERON CORP48 citations88
US7622549B2Nov 24, 2009
Human telomerase reverse transcriptase polypeptides
GERON CORP8 citations84
US7560437B2Jul 14, 2009
Nucleic acid compositions for eliciting an immune response against telomerase reverse transcriptase
GERON CORP11 citations84
US7517971B1Apr 14, 2009
Muteins of human telomerase reverse transcriptase lacking telomerase catalytic activity
GERON CORP9 citations84
US7413864B2Aug 19, 2008
Treating cancer using a telomerase vaccine
GERON CORP9 citations84
US7750121B2Jul 6, 2010
Antibody to telomerase reverse transcriptive
GERON CORP5 citations74
US10196677B2Feb 5, 2019
Method for identification of sensitivity of a patient to telomerase inhibition therapy
GERON CORP1 citations72
US9617583B2Apr 11, 2017
Method for identification of sensitivity of a patient to telomerase inhibition therapy
GERON CORP1 citations62
UNIV COLORADO
5 patentsUS7262288B1Aug 28, 2007
Nucleic acids encoding human telomerase reverse transcriptase and related homologs
UNIV COLORADO42 citations96
US7056513B2Jun 6, 2006
Telomerase
UNIV COLORADO28 citations96
US7285639B2Oct 23, 2007
Antibody to telomerase reverse transcriptase
UNIV COLORADO20 citations93
US7195911B2Mar 27, 2007
Mammalian cells that have increased proliferative capacity
UNIV COLORADO31 citations93
US7005262B2Feb 28, 2006
Methods for detecting nucleic acids encoding human telomerase reverse transcriptase
UNIV COLORADO21 citations93
UNIV TEXAS
3 patentsUS5645986AJul 8, 1997
Therapy and diagnosis of conditions related to telomere length and/or telomerase activity
UNIV TEXAS98 citations96
US6007989ADec 28, 1999
Methods of screening for compounds that derepress or increase telomerase activity
UNIV TEXAS53 citations94
US6551774B1Apr 22, 2003
Diagnostic methods for conditions associated with elevated cellular levels of telomerase activity
UNIV TEXAS9 citations72
CECH THOMAS R
3 patentsUS8222392B2Jul 17, 2012
Kit for detection of telomerase reverse transcriptase nucleic acids
CECH THOMAS R12 citations91
US8236774B2Aug 7, 2012
Human telomerase catalytic subunit
CECH THOMAS R8 citations84
US8709995B2Apr 29, 2014
Method for eliciting an immune response to human telomerase reverse transcriptase
CECH THOMAS R6 citations82
HARLEY CALVIN B
3 patentsUS8481721B2Jul 9, 2013
Compositions and methods for increasing telomerase activity
HARLEY CALVIN B5 citations77
US8877723B2Nov 4, 2014
Method for identification of sensitivity of a patient to telomerase inhibition therapy
HARLEY CALVIN B4 citations71
US9248088B2Feb 2, 2016
Compositions and methods for skin conditioning
HARLEY CALVIN B5 citations69